AI assistant
MERIT MEDICAL SYSTEMS INC — Director's Dealing 2020
Mar 17, 2020
31049_dirs_2020-03-17_7fb566d6-0cfd-49cd-95f9-d5afca4a649b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MERIT MEDICAL SYSTEMS INC (MMSI)
CIK: 0000856982
Period of Report: 2020-03-13
Reporting Person: Wright Joseph (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-03-13 | Common Stock, No Par Value | M | 10000 | $13.14 | Acquired | 10000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-03-13 | Non-qualified stock options (right to buy) | $13.14 | M | 10000 | Disposed | 2020-07-31 | Common Stock (10000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-qualified stock options (right to buy) | $12.06 | 2021-10-04 | Common Stock (25000) | 25000 | Direct |
| Non-qualified stock options (right to buy) | $17.27 | 2022-02-13 | Common Stock (10000) | 10000 | Direct |
| Non-qualified stock options (right to buy) | $16.05 | 2023-01-28 | Common Stock (20000) | 20000 | Direct |
| Non-qualified stock options (right to buy) | $28.20 | 2024-04-14 | Common Stock (25000) | 25000 | Direct |
| Non-qualified stock options (right to buy) | $44.80 | 2025-03-02 | Common Stock (25000) | 25000 | Direct |
| Non-qualified stock options (right to buy) | $55.73 | 2026-03-01 | Common Stock (30000) | 30000 | Direct |
| Non-qualified stock options (right to buy) | $37.71 | 2027-02-26 | Common Stock (16722) | 16722 | Direct |
| Performance Stock Units | $ | 2023-03-15 | Common Stock (7955) | 7955 | Direct |
Footnotes
F1: Becomes exercisable in equal annual installments of 20% commencing on 07/31/2014.
F2: Becomes exercisable in equal annual installments of 20% commencing on 10/04/2015.
F3: Becomes exercisable in equal annual installments of 20% commencing on 02/13/2016.
F4: Becomes exercisable in equal annual installments of 20% commencing on 01/28/2017.
F5: Becomes exercisable in equal annual installments of 20% commencing on 04/14/2018.
F6: Becomes exercisable in equal annual installments of 20% commencing on 03/02/2019.
F7: Becomes exercisable in equal annual installments of 20% commencing on 03/01/2020.
F8: Becomes exercisable in equal annual installments of 25% commencing on 02/26/2021.
F9: Each performance share unit represents the Company's commitment to issue one share of Merit Medical Systems, Inc. common stock, subject to achievement of performance criteria.
F10: If earned by the Reporting Person, the PSUs will be awarded not later than March 15 of the year following the Issuer's achievement of the target level of free cash flow, subject to conditions set forth in the Performance Stock Unit Award Agreement.
F11: On February 26, 2020, the reporting person was awarded a target number of performance share units (''PSUs'') pursuant to a Performance Stock Unit Award Agreement by and between the Reporting Person and the Issuer. The actual number of PSUs to be awarded to the Reporting Person will be based upon the Issuer's free cash flow measured against its 2020 financial plan over one, two and three-year periods ending December 31, 2020, 2021 and 2022, respectively, and subject to the Reporting Person's continued employment with the Issuer and the conditions set forth in the Stock Unit Award Agreement.